BioCentury
ARTICLE | Company News

Management tracks

December 10, 2016 1:07 AM UTC

GlaxoSmithKline plc (LSE:GSK; NYSE:GSK) said Deborah Waterhouse will succeed Dominique Limet at CEO of Viiv Heathcare, its HIV-focused joint venture with Pfizer Inc. (NYSE:PFE) and Shionogi & Co. Ltd. (Tokyo:4507). Limet is to step down in March 2017. Waterhouse is SVP of primary care at GSK's U.S. Pharmaceuticals subsidiary.

Gene therapy company Spark Therapeutics Inc. (NASDAQ:ONCE) hired John Furey as COO, a newly created position. He was SVP and head of global operations at Baxalta Inc., which was acquired by Shire plc (LSE:SHP; NASDAQ:SHPG). ...